Market revenue in 2021 | USD 447.5 million |
Market revenue in 2030 | USD 979.3 million |
Growth rate | 9.1% (CAGR from 2021 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Preclinical |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preclinical, Clinical |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 67.13% in 2021. Horizon Databook has segmented the Europe large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
European region spearheads in microbial manufacturing technology, which represents the R&D effort by this region at the global level. Various developing countries across the globe are seeking partnerships with the Western giants to establish their own domestic capability by providing support services to the industry, consisting of clinical research, toxicity testing, drug development, etc.
Pharmaceutical and biotechnology industries in Europe have made significant investments on R&D in the recent years owing to rising demand for advanced medicines. This can be attributed to increasing aging population and growing incidence of chronic & communicable diseases. For instance, more than one fifth of the European population was aged 65 or above in 2019.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe large molecule bioanalytical testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Europe large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account